|
|
| Anticipated Data from Transformative Trials at ASCO GU 2022
|
Alicia Morgans, MD, MPH and Oliver Sartor, MD
Alicia Morgans and Oliver Sartor discuss the upcoming American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium on Feb 17-19, 2022, and the data from key presentations in prostate cancer, bladder cancer, and kidney cancer.
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
SELECT SESSIONS OF NOTE AT THE UPCOMING 2022 ASCO GU CANCERS SYMPOSIUM |
|
|
|
|
|
|
|
|
Chairs: Felix Feng, MD and Peter Hoskin, FRCP, FRCR, MD
Session: Novel Treatment Implementation: Prostate-Specific Membrane Antigen Targeting and Beyond |
|
|
|
|
|
|
|
|
|
|
|
|
Chair: Karim Fizazi, MD, Ph.D.
Session: Evolution of Multidisciplinary Management Across the Spectrum of Prostate Cancer |
|
|
|
|
|
|
|
|
|
|
|
Chair: Hala Borno, MD
Session: Rapid Abstract Session A: Prostate Cancer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chair: Stephen A. Boorjian, MD
Session: Rapid Abstract Session B: Urothelial Carcinoma
|
|
|
|
|
|
|
|
|
|
|
|
Chairs: Sam Chang, MD, MBA and Matthew Milowsky, MD, FASCO
Session: Novel Therapies and Their Toxicities in Bladder Cancer |
|
|
|
|
|
|
|
|
|
|
|
|
Chairs: Todd Morgan, MD and Andrea Apolo, MD
Session: Oral Abstract Session B: Urothelial Carcinoma |
|
|
|
|
|
|
|
|
|
|
|
|
Chairs: Wassim Kassouf, MD, FRCS and Evan Yu, MD
Session: Demystifying Next-Generation Sequencing in Urothelial Carcinoma: A Case-Based Approach |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chair: Robert Uzzo, MD, MBA
Session: Rapid Abstract Session C: Renal Cell Cancer and Rare Tumors
|
|
|
|
|
|
|
|
|
|
|
|
Chairs: Robert Dreicer, MD, MS, MACP, FASCO and Katie Murray, DO, MS
Session: Management of Rare Variants in Genitourinary Cancers |
|
|
|
|
|
|
|
|
|
|
| 2022 ASCO GU Cancers Symposium Program Designed to Ignite Multidisciplinary Approach to Care |
|
|
|
|
|
|
| Planning Your Meeting Experience: How to Register, Access the Content, and More |
|
|
|
|
|
|
| Attend In-Person and Online Networking Opportunities |
|
|
|
|
|
|
| Dr. Karen E. Knudsen to Address GU Malignancy Disparities During Keynote Lecture |
|
|
|
|
|
|
| Attend Industry Expert Theater Sessions |
|
|
|
|
|
|
| Plan to Attend Ancillary Educational Events |
|
|
|
|
|
|
|
|
 |